PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis- Transit Week 52 Results
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2075
https://www.valueinhealthjournal.com/article/S1098-3015(12)03788-6/fulltext
Title :
PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis- Transit Week 52 Results
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03788-6&doi=10.1016/j.jval.2012.08.2075
First page :
A573
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
1559